Table 2 Demographic and Clinical Characteristics: Post RAS Inhibitors
| Ā | Unadjusted | Inverse probability weighted adjusted | Matched | Data | Ā | ||||
|---|---|---|---|---|---|---|---|---|---|
PostRASi (nā=ā2831) | No-PostRASiI (nā=ā5299) | p-value | PostRASi (nā=ā2831) | No-PostRASi (nā=ā5299) | p-value | PostRASi (nā=ā2673) | No-PostRASi (nā=ā2673) | p-value | |
Age | 65.8ā±ā11.9 | 64.7ā±ā13.2 | 0.0004 | 65.2ā±ā20.5 | 65.1ā±ā15.4 | 0.57 | 65.7ā±ā12 | 65.8ā±ā12.3 | 0.86 |
Male | 68.4 | 68.6 | 0.82 | 68.7 | 68.5 | 0.63 | 68.4 | 68.4 | 0.98 |
BMI | 29.1ā±ā6.2 | 28.8ā±ā6.2 | 0.09 | 28.9ā±ā10.2 | 28.4ā±ā7.5 | 0.64 | 29.1ā±ā6.2 | 29.0ā±ā6.2 | 0.61 |
Diabetes | 37.8 | 29.5 | <0.0001 | 32.7 | 32.5 | 0.64 | 36.2 | 35.9 | 0.80 |
Smoker | 38.7 | 41.3 | 0.02 | 39.8 | 40.3 | 0.67 | 39.5 | 39.7 | 0.85 |
Hypertension | 83.7 | 73.9 | <0.0001 | 78.2 | 78.5 | 0.42 | 83.0 | 83.7 | 0.49 |
Cerebrovascular disease | 16.8 | 16.0 | 0.34 | 16.1 | 16.7 | 0.53 | 17.0 | 16.3 | 0.53 |
Peripheral arterial disease | 13.1 | 11.6 | 0.06 | 12.1 | 12.3 | 0.75 | 12.8 | 11.9 | 0.30 |
Chronic lung disease | 18.5 | 19.5 | 0.30 | 19.40 | 19.0 | 0.82 | 18.8 | 18.7 | 0.94 |
Family history CAD | 39.1 | 39.5 | 0.68 | 39.0 | 38.8 | 0.61 | 39.3 | 40.3 | 0.78 |
Angina | 39.3 | 34.1 | <0.0001 | 35.1 | 35.8 | 0.72 | 38.5 | 38.8 | 0.78 |
Congestive heart failure | 32.3 | 27.7 | 0.0001 | 30.4 | 30.5 | 0.86 | 31.3 | 30.7 | 0.62 |
Previous MI | 36.5 | 30.2 | <0.0001 | 32.1 | 33.0 | 0.81 | 35.4 | 35.8 | 0.75 |
Discharge beta blockers | 83.1 | 82.1 | 0.07 | 83.1 | 82.9 | 0.32 | 83.2 | 83.9 | 0.61 |
Discharge aspirin | 85.7 | 84.2 | 0.03 | 85.7 | 85.8 | 0.69 | 86.8 | 85.1 | 0.25 |
Discharge lipid lowering | 81.0 | 79.5 | 0.07 | 80.3 | 80.1 | 0.46 | 81.9 | 89.7 | 0.74 |
Discharge warfarin | 24.5 | 22.8 | 0.07 | 24.0 | 23.5 | 0.35 | 24.1 | 22.0 | 0.15 |
Urgent | 53.9 | 49.3 | 0.001 | 51.9 | 50.7 | 0.61 | 52.8 | 53.1 | 0.83 |
CABG | 58.5 | 54.6 | 0.001 | 56.2 | 55.9 | 0.36 | 58.0 | 59.1 | 0.42 |
Valve | 25.6 | 27.1 | 0.13 | 26.2 | 26.7 | 0.59 | 25.9 | 25.4 | 0.68 |
Pre RAS inhibitor | 56.9 | 34.7 | <0.0001 | 42.9 | 42.2 | 0.87 | 54.6 | 54.1 | 0.70 |